Korean J Anesthesiol.  2011 Nov;61(5):431-434. 10.4097/kjae.2011.61.5.431.

The prophylactic use of recombinant factor VIIa in a patient with DeBakey type III aortic dissection: A case report

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. icchoi@amc.seoul.kr

Abstract

Little is known about the prophylactic use of recombinant factor VIIa (rFVIIa) in patients undergoing surgery for a bleeding aorta employing cardiopulmonary bypass. We report the successful use of rFVIIa in a patient undergoing hypothermic circulatory arrest and prolonged cardiopulmonary bypass for repair of a DeBakey type III aortic dissection.

Keyword

Aortic surgery; Recombinant factor VIIa; Transfusion

MeSH Terms

Aorta
Cardiopulmonary Bypass
Factor VIIa
Hemorrhage
Humans
Recombinant Proteins
Factor VIIa
Recombinant Proteins
Full Text Links
  • KJAE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr